This should be an interesting few weeks with this stock. A decision with the litigation, new management, and good news with their new drug. The future is looking bright.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.